Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Single cell RNA-sequencing of C134 oHSV-treated murine medulloblastoma

ABSTRACT: Single cell RNA-sequencing of C134 oHSV-treated murine medulloblastoma

PROVIDER: PRJNA822627 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18579954.fastq.gz	Fastqsanger.gz
	SRR18579955.fastq.gz	Fastqsanger.gz
	SRR18579956.fastq.gz	Fastqsanger.gz
	SRR18579957.fastq.gz	Fastqsanger.gz
	SRR18579958.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

Single cell RNA-sequencing of C134 oHSV-treated murine medulloblastoma

Project description:Here, we studied the effects of oHSV C134 in two syngeneic medulloblastoma mouse models, one that aligns with the sonic hedgehog (SHH) subtype (MYCN) and another that aligns with tumors of the group 3 subtype (CMYC).We harvested tumor tissue two and six days post-injection of C134 and performed single cell RNA-sequencing (scRNA-seq).

2023-07-27 | GSE200008 | GEO

Single cell RNA-sequencing of M002 oHSV-treated murine glioblastoma

Project description:In this study, we evaluated the effects of M002 oncolytic herpes simplex virus (oHSV) in a syngeneic intracranial glioblastoma stem cell model. We harvested tumor-bearing mouse brain tissue 45 days post-injection of M002 oHSV and performed single-cell RNA-sequencing (scRNA-seq).

2024-12-03 | GSE246895 | GEO

Transcriptomic analysis of E0771 tumors treated with FEC + oHSV-1 Vs PBS

Project description:E0771 tumors were implanted either subcutaneously on the left flank or orthotopically in the mammary fat pad and treated with either PBS or FEC + oHSV-1 Mice were sacrificed 5 days after the start of treatment and whole tumour digests were used for RNA extraction

2021-10-01 | GSE183864 | GEO

IDH status dictates oHSV mediated metabolic reprogramming affecting anti-tumor immunity

Project description:Identification of IDH mutations has uncovered the crucial role played by metabolism in glioma-genesis. Oncolytic herpes virus (oHSV) therapy initiates direct tumor debulking by tumor lysis and also activates antitumor immunity however little is known about the role of glioma metabolism in determining oHSV efficacy. Here we identified that oHSV therapy rewired central carbon metabolism with increased glucose utilization towards oxidative phosphorylation and shuttled glutamine towards reductive carboxylation in IDH wildtype (wt) glioma. The switch in metabolism resulted in increased lipid synthesis, and cellular ROS. PKC induced ACSL4 in oHSV treated cells led to lipid peroxidation and ferroptosis. Ferroptosis was critical to launch an antitumor immune response important for efficacy. Mutant IDH (IDHR132H) gliomas are incapable of reductive carboxylation and hence ferroptosis. Pharmacological blockade of IDHR132H induced ferroptosis and antitumor immunity. This study provides a rationale to treat high grade IDHR132H glioma patients under oHSV treatment with IDHR132H inhibitor.

2025-04-02 | GSE289317 | GEO

oHSV Drives Tertiary Lymphoid Structure Boosting Oral Cancer Immunotherapy

Project description:The formation of TLSs induced by oncolytic virus treatment can enhance the anti-tumor response of oral cancer. Therefore, oncolytic virotherapy in vivo is a good strategy. To understand the mechanism of post-treatment changes, we collected oHSV-treated tumors for RNA-seq.

2025-01-08 | GSE262913 | GEO

Transcriptomic analysis of E0771 tumors treated with FEC + oHSV-1 Vs PBS

Project description:Transcriptomic analysis of E0771 tumors treated with FEC + oHSV-1 Vs PBS

| PRJNA762241 | ENA

Single-cell RNAseq of childhood medulloblastoma

Project description:Single-cell RNAseq of childhood medulloblastoma

| PRJNA649773 | ENA

Myc-driven medulloblastoma cells treated with Panobinostat (LBH589)

Project description:Mouse MycT58A/DNp53 (MP) medulloblastoma cells were treated with DMSO or HDAC inhibitor (HDACi) panobinostat for 6 or 12 hours in vitro. Gene expression profiling was performed to compare cells treated with panobinostat and DMSO.

2015-06-02 | GSE69410 | GEO

Project description:Single cell RNA-sequencing of M002 oHSV-treated murine glioblastoma

| PRJNA1034615 | ENA

Single-cell RNAseq of childhood medulloblastoma

Project description:We explore cellular heterogeneity in 28 childhood medulloblastoma (MB) (1 WNT, 9 SHH, 7 GP3 and 11 GP4) using single-cell RNA sequencing (scRNA-seq), immunohistochemistry and deconvolution of bulk transcriptomic data. Neoplastic cells are broadly clustered according to subgroup, and within subgroups discrete sample clustering is associated with chromosomal copy number variance. Each subgroup contains subpopulations exhibiting mitotic , undifferentiated and neuronal differentiated transcript profiles , corroborating other recent medulloblastoma scRNA-seq studies and identifying new subpopulations. We identify a photoreceptor-differentiated subpopulation that is predominantly found in GP3 medulloblastoma, and in SHH, a subpopulation that constitutes differentiating nodules . Deconvolution of a large transcriptomic dataset shows that neoplastic subpopulations are associated with major and minor subgroup subdivisions, for example, photoreceptor subpopulation cells are more abundant in GP3-alpha. This scRNA-seq dataset also demonstrates medulloblastoma subgroup-specific differences in the tumor microenvironment and immune landscape, and reveals an SHH nodule -associated myeloid subpopulation. Additionally, we perform scRNA-seq on genetically engineered mouse (GEM) models of GP3 and SHH medulloblastoma. These models specifically matched the corresponding human subgroup-specific neoplastic subpopulations. We provide an interactive online resource that facilitates exploration of these MB single cell datasets. Collectively, our findings advance our understanding of the neoplastic and immune landscape of the main medulloblastoma subgroups in both humans and GEM models.

2021-06-04 | GSE155446 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data